BSKB News
Learn about BSKB’s announcements, recognitions, and other firm news below.
-
May 12, 2020
BSKB Partners Invited to Speak at Joint Seminar Hosted by UBIC Patent Partners in Tokyo, Japan
BSKB partners Marc Weiner, Rick Anderson and Chad Billings have been invited to lecture at a seminar hosted by UBIC Patent Partners in Tokyo, Japan on April 23, 2014. Mr. Hajime Shirasaka of UBIC Patent Partners will be both host and one of the speakers at the joint seminar.
-
April 6, 2020
Intel, Apple Using Antitrust as New Weapon in Patent Fights
Tech giants are testing the water of new legal theories It could subject non-practicing corporate entities to additional scrutiny Two Silicon Valley giants are testing a relatively new legal argument that non-practicing corporate entities that hoard patents and make aggressive demands can commit antitrust violations.
-
May 12, 2020
BSKB Partner MaryAnne Armstrong, Ph.D., to Present ACS Webinar on Collaborative Research Considerations
MaryAnne Armstrong, Ph.D., partner at BSKB, will present a webinar entitled “Pitfalls to Avoid in Collaborative Research” for the Chemistry and the Law (CHAL) division of the American Chemical Society (ACS). The webinar will take place on Tuesday, April 11, 2017 from 2:00 – 3:00pm EDT, and there is no cost to attend. The CHAL webinar series is focused on patent-related topics of interest to chemists, and this webinar will focus on collaborative research considerations.
-
May 11, 2020
Partner Charles Gorenstein Quoted in IP360 Article on Yahoo v. Facebook Case
BSKB partner Charles Gorenstein was quoted in a March 14, 2012 Intellectual Property Law360 article about Yahoo’s latest suit against Facebook, filed this week in a California court. The case, which alleges that Facebook infringes on 10 Yahoo patents related to advertising, privacy and social networking, is being watched closely for its impact on Yahoo’s faltering bottom line. According to Mr. Gorenstein, however, “a patent suit is probably not going to be at the forefront of most consumers’ minds.” He explains in the article, “I don’t know that the fact that this occurred is going to cause people to not use Yahoo.” Subscribers can read the full article on Law360’s website.
-
May 12, 2020
BSKB Partners Marc S. Weiner and MaryAnne Armstrong, Ph.D., to Present Lectures to JPAA Regarding Post Grant Patent Proceedings
BSKB partners Marc S. Weiner and MaryAnne Armstrong, Ph.D., have been invited to speak in Tokyo, Japan to members of the Japan Patent Attorneys Association (JPAA) on October 16, 2012. They will present a lecture on the topic of post grant patent proceedings, explaining when each type of procedure can be used and the advantages and disadvantages of each procedure.
-
April 6, 2020
LeBron Tries to Outmaneuver Charity Over ‘More Than An Athlete’
LeBron James’ spat with a youth nonprofit over a simple t-shirt slogan is morphing into a complex trademark battle that could hinge on whether his acquisition of an earlier mark protects him from infringement charges.
-
May 12, 2020
BSKB Partner Gerald Murphy to Speak at 2015 PLI Patent Law Institute
BSKB partner Gerald M. Murphy, Jr. has been invited to speak at the Practising Law Institute (PLI)’s 2015 Patent Law Institute. The 2015 Patent Law Institute will be held in New York, NY on February 2-3, 2015, and in San Francisco, CA on March 16-17, 2015. The seminar provides up to date information about U.S. patent law from seasoned practitioners, who lead breakout sessions that go into depth on such issues as prosecution and litigation. Mr. Murphy has been a speaker at the annual Patent Law Institute since 2009.
-
May 12, 2020
BSKB Partners Gerald Murphy and Craig McRobbie to Present at 2017 PLI Patent Law Institute
BSKB partners Gerald M. Murphy, Jr. and Craig A. McRobbie will present lectures on chemical, pharmaceutical and biotech patent prosecution and post grant practice at the Practising Law Institute (PLI)’s 11th Annual Patent Law Institute in April 2017. The annual Patent Law Institute is directed towards patent prosecutors, patent litigators and strategic/transactional lawyers, and features plenary sessions as well as separate breakout sessions for each subgroup of practitioners. Other featured speakers include federal judges, government officials, academics and in-house counsel, and the sessions will cover updates to laws affecting patent practice as well as practical suggestions for practitioners. The 2017 Patent Law Institute will be held in New York, NY on April 6-7, 2017 and in San Francisco, CA and via webcast on April 27-28, 2017. Mr. Murphy and Mr. McRobbie have been speakers at the Patent Law Institute since 2009 and 2016, respectively.
-
May 11, 2020
Law360 Article Features Advice from BSKB Partners James M. Slattery and John W. Bailey
BSKB partners James M. Slattery and John W. Bailey were featured in the recent Law360 article “Welcome To The Club: Advice From Old To New Partners.” Veteran partners were asked to offer advice based on their years of experience to those recently promoted to the role.
-
May 11, 2020
Partner MaryAnne Armstrong, Ph.D. comments on the Federal Circuit’s recent precedential decision in Natural Alternatives International Inc. v. Creative Compounds LLC.
Read the full article here.
-
May 11, 2020
Andrew Meikle Presents on AIA Strategies at FICPI ABC Meeting
BSKB partner Andrew D. Meikle participated in the Fédération Internationale des Conseils en Propriété Industrielle (FICPI) ABC Meeting in New Orleans, where he presented a lecture entitled “How the USPTO Rules Implement the AIA: Prosecution Strategies and Tips.” The meeting took place May 15 – 18, 2013. Mr. Meikle is President-Elect of the U.S. Section of FICPI.
-
May 8, 2020
CAFC Reverses USPTO Ruling on Leo Pharma Patent
The Federal Circuit reversed a USPTO decision of obviousness and claim construction on Leo Pharmaceutical Products Ltd.’s psoriasis drug patent on Monday, August 12, 2013. The Federal Circuit’s decision to reverse the USPTO’s conclusion (Director Rea) that the patent was unpatentable was made after finding that Leo Pharmaceutical’s invention solved the long-felt but unmet need of storage stability of the drug, which the prior art did not address. The Federal Circuit also found that the USPTO erred in its claim construction of “storage stable” in the reexamined patent claims. BSKB’s Andrew Meikle, Leonard Svensson, and Eugene Perez are among the representatives of Leo Pharmaceuticals Products Ltd. The inter partes reexamination control number is 95/000153 and was originally filed in 2006.
-
May 12, 2020
BSKB Partners to Speak on U.S. Patent Law Changes to INFOPAT Group in Japan
BSKB partners Marc S. Weiner and Eugene T. Perez have been invited to speak in Tokyo, Japan to members of the Association for the Study of International & Foreign Patent Trademark Laws & Practice (INFOPAT) on May 10, 2012. Their lecture, entitled “First Inventor to File, Prior Art and Priority under the Leahy-Smith America Invents Act: Transitioning to the New U.S. Patent Law,” will cover the changes to 35 U.S.C. §§ 102 (anticipation) and 103 (obviousness/inventive step) due to the 2011 America Invents Act (AIA). This lecture will also cover §§ 102/103 before and after the effective law date of March 16, 2013, as well as specific topics such as the 1-year grace period, when U.S. patents and patent application publications are available as prior art, and filing by an assignee.
-
May 12, 2020
Andrew Meikle to Speak at FICPI’s 16th Open Forum in St. Petersburg
BSKB partner Andrew D. Meikle will speak at the Fédération Internationale des Conseils en Propriété Industrielle (FICPI) 16th Open Forum, held October 5-8, 2016, in St. Petersburg, Russia. Mr. Meikle, who is President of the U.S. section of FICPI, will be speaking on a panel addressing how companies can better protect their inventions and improve internal processes, such as communication with inventors. The FICPI Open Forum offers attendees from around the world a chance to come together to discuss the changing landscape of IP, with specialized sessions for patent attorneys and trademark attorneys, as well as sessions on business practice issues.
-
May 12, 2020
BSKB Partners Gerald Murphy and Craig McRobbie to Present at 2016 PLI Patent Law Institute
BSKB partners Gerald M. Murphy, Jr. and Craig A. McRobbie will present lectures on chemical, pharmaceutical and biotech patents at the Practising Law Institute (PLI)’s 10th Annual Patent Law Institute in 2016. The 2016 Patent Law Institute will be held in New York, NY on April 14-15, 2016, and in San Francisco, CA on May 5-6, 2016. Mr. Murphy has been a speaker at the annual Patent Law Institute since 2009.
-
May 11, 2020
Intellectual Property Watch Quotes Michael K. Mutter on the Case of Alice Corp. v. CLS
BSKB partner Michael K. Mutter was quoted in a recent Intellectual Property Watch article on the case of Alice Corp. v. CLS. Regarding the decision of Federal Circuit on this case, he said, “I don’t think anyone right now knows what the law is.” Mr. Mutter was also quoted as saying, “You have a 50-50 divided Federal Circuit producing diametrically opposed opinions. I’ve been doing this for 34 years, and I’ve never seen anything like this before.”
-
May 11, 2020
Twitter Terms of Service Do Not Provide “Others” with Affirmative Defense to Copyright Infringement
Absent a statement to the contrary, content on the Internet is not dedicated to the public domain and free for all to reproduce and distribute
-
May 12, 2020
BSKB Partner Eugene T. Perez to Speak at 2014 PLI Patent Law Institute
BSKB partner Eugene T. Perez has been invited to speak at the Practising Law Institute (PLI)’s Patent Law Institute. The 2014 Patent Law Institute will be held in New York, NY on May 8, 2014, and in San Francisco, CA on June 17, 2014. The seminar provides up to date information about U.S. patent law from seasoned practitioners, who lead breakout sessions that go into depth on such issues as prosecution and litigation.
-
May 8, 2020
BSKB Partner MaryAnne Armstrong Quoted in WIPR Article Regarding Alfred E. Mann Foundation for Scientific Research v. Cochlear Corp. Decision
BSKB partner MaryAnne Armstrong, Ph.D., was quoted in a recent WIPR article regarding the Alfred E. Mann Foundation for Scientific Research v. Cochlear Corp. decision. In the article, Dr. Armstrong stated because “presumably the infringement has been spread” over about seven years, and that Cochlear reported revenues of about $750 million last year, the damages award might “not be so unreasonable” for Cochlear.
-
May 12, 2020
BSKB Partner Eugene T. Perez to Speak at Managing IP U.S. Patent Forum in Washington D.C.
BSKB partner Eugene T. Perez will speak at the Managing IP (MIP) U.S. Patent Forum 2014 in Washington D.C to present “Post-Grant Proceedings in the U.S.” The panel will discuss: